Mar 8 2019
Notebook: SHP2 is required for growth of KRAS-mutant non-small-cell lung cancer in vivo
Recently Dr. Mainardi S, et al. found SHP2 is required for growth of KRAS-mutant non-small-cell lung cancer. Research published at Nature Medicine on May 28, 2018. Lung cancer is the most common cause of cancer death worldwide, about 1.6 million deaths every year. Non-small cell lung cancer (NSCLC) is the primary type of lung cancer […]
Mar 8 2019
Notebook: Synergy between the KEAP1/NRF2 and PI3K Pathways Drives Non-Small-Cell Lung Cancer with an Altered Immune Microenvironment
Dr. Best S A et al recently report their finding on NSCLC and KEAP1/NRF2 and PI3K Pathways[1]. It is well known that non-small cell lung cancer is the most common type of lung cancer, with a lower survival rate in most cancer.Adenocarcinoma (ADC) is the major histological subtype of lung cancer and the KEAP1/NRF2 pathway […]
Read More
By Admin • News • 0